Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
QuatRx Pharmaceuticals Company
With
Hormos Medical
Age
20–any
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
Hypogonadal (morning total testosterone levels ≤400 ng/dl) men age ≥20 with ED who are unresponsive to PDE5 inhibitors, as demonstrated by International Index of Erectile Function (IIEF) results for 28-day lead in period.
Clareo Health | Efficacy and Safety Evaluating Fispemifene in the Treatment of Hypogonadal Men With Erectile Dysfunction Unresponsive to PDE5 Inhibitors
